Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin in Acute Heart Failure Syndromes
NCT02544815Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- May 2023
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of digoxin in Acute Heart Failure (AHF), sponsored by Université de Monastir. Started May 2023; status: completed.
02
Drugs
digoxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT02544815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544815.